- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Over 10 countries looking to imbibe India's generic pharmacy model: Report
New Delhi: In an effort to provide affordable medicines to the public, more than 10 countries are looking to imbibe India's generic pharmacy model, as per recent reports.
Mauritius became the first nation to unveil the International Janaushadhi Kendra in July, facilitating access to around 250 high-quality medicines sourced from the Pharmaceuticals and Medical Devices Bureau of India (PMBI). These medicines includes cardiovascular, analgesic, ophthalmic, and anti-allergic drugs.
According to IANS, Nepal, Sri Lanka, Bhutan, Ghana, Suriname, Nicaragua, Mozambique, the Solomon Islands, and Taliban-ruled Afghanistan, are already considering opening Jan Aushadhi Kendras.
Meanwhile, countries like Burkina Faso, Fiji Islands, and Saint Kitts and Nevis are in talks with the government to help them replicate the scheme, revealed the report.
Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP) is a public welfare scheme, launched by the Prime Minister Narendra Modi-led Central government in November 2008, to provide quality medicines at affordable prices to the masses through special centres named Jan Aushadhi Kendras.
In 2014, there were only 80 Jan Aushadhi Kendras. Till September 2024, a total of 13,822 Jan Aushadhi Kendras have been established across the country, as per official data.
In September, these Kendras also achieved record sales of Rs 200 crore -- the highest monthly sales in the history of the PMBJP.
In the last 10 years, the sale of medicines worth Rs. 6100 crores has been done through Kendras, helping people save an estimated Rs. 30,000 crore.
The price of medicines, surgical devices and nutraceutical products are cheaper at least by 50 per cent at the Jan Aushadhi Kendras, and in some cases, by 80 to 90 per cent of the market price of branded medicines.
The Union government has set a target of opening 25,000 Jan Aushadhi Kendras across the country by March 2026.
Read also: Record sales of Rs 200 crore achieved by Jan Aushadhi Kendras in September
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751